Free Trial

Best Stocks Under $20 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $20.00 (20 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Glencore stock logo

1. Glencore OTCMKTS:GLNCY

$7.90 -0.08 (-1.00%)
As of 03:11 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about Glencore

Market Capitalization
$47.10 billion
Consensus Rating
Strong Buy
Volume
347,722 shares
Average Volume
1.02 million shares
Today's Range
$7.83
$7.95
50-Day Range
$7.30
$8.84
Galp Energia SGPS stock logo

2. Galp Energia SGPS OTCMKTS:GLPEY

$9.37 -0.14 (-1.47%)
As of 03:03 PM Eastern

Galp Energia, SGPS, SA operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Midstream, Commercial, and Renewables and New Business. More about Galp Energia SGPS

Market Capitalization
$13.03 billion
P/E Ratio
13.20
Consensus Rating
Strong Buy
Volume
38,823 shares
Average Volume
87,739 shares
Today's Range
$9.28
$9.40
Birchcliff Energy stock logo

3. Birchcliff Energy OTCMKTS:BIREF

$4.81 -0.09 (-1.84%)
As of 01:12 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.31 billion
P/E Ratio
13.74
Consensus Rating
Strong Buy
Volume
9,642 shares
Average Volume
86,716 shares
Today's Range
$4.80
$4.88
Ivanhoe Mines stock logo

4. Ivanhoe Mines OTCMKTS:IVPAF

$7.74 -0.07 (-0.85%)
As of 03:11 PM Eastern

Ivanhoe Mines Ltd. engages in the mining, development, and exploration of minerals and precious metals primarily in Africa. More about Ivanhoe Mines

Market Capitalization
$10.48 billion
P/E Ratio
15.65
Consensus Rating
Strong Buy
Volume
115,616 shares
Average Volume
335,112 shares
Today's Range
$7.63
$7.98
Artelo Biosciences stock logo

5. Artelo Biosciences NASDAQ:ARTL

$10.20 -1.66 (-14.00%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Artelo Biosciences, Inc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. More about Artelo Biosciences

Market Capitalization
$7.18 million
P/E Ratio
-0.57
Consensus Rating
Strong Buy
Consensus Price Target
$25.00 (+145.1% Upside)
Volume
592,523 shares
Average Volume
308,919 shares
Adyen stock logo

6. Adyen OTCMKTS:ADYEY

$16.74 -0.46 (-2.69%)
As of 03:11 PM Eastern

Adyen N.V. operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, Latin America. More about Adyen

Market Capitalization
$52.74 billion
Consensus Rating
Buy
Volume
855,200 shares
Average Volume
648,009 shares
Today's Range
$16.59
$16.84
50-Day Range
$17.20
$19.88
Weir Group stock logo

7. Weir Group OTCMKTS:WEGRY

$17.59 -0.01 (-0.03%)
As of 07/31/2025 03:50 PM Eastern

The Weir Group PLC produces and sells highly engineered original equipment worldwide. It operates in two segments, Minerals and ESCO. More about Weir Group

Consensus Rating
Buy
Volume
520 shares
Average Volume
5,547 shares
Today's Range
$17.59
$17.71
50-Day Range
$15.77
$18.10
52-Week Range
$11.80
$18.10
OS Therapies stock logo

8. OS Therapies NYSE:OSTX

$1.74 -0.04 (-1.97%)
As of 03:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$49.03 million
P/E Ratio
-2.03
Consensus Rating
Buy
Consensus Price Target
$18.00 (+931.5% Upside)
Volume
257,845 shares
Average Volume
736,482 shares
Ultrapar Participacoes stock logo

9. Ultrapar Participacoes NYSE:UGP

$3.08 +0.03 (+0.82%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$3.44 billion
P/E Ratio
8.57
Consensus Rating
Buy
Consensus Price Target
$3.20 (+3.7% Upside)
Volume
2.29 million shares
Average Volume
1.90 million shares
Select Water Solutions stock logo

10. Select Water Solutions NYSE:WTTR

$9.14 -0.50 (-5.14%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Select Water Solutions, Inc, together with its subsidiaries, provides water management and chemical solutions to the energy industry in the United States. More about Select Water Solutions

Market Capitalization
$1.10 billion
P/E Ratio
26.87
Consensus Rating
Buy
Consensus Price Target
$14.88 (+62.8% Upside)
Volume
924,102 shares
Average Volume
1.25 million shares
Telecom Italia stock logo

11. Telecom Italia OTCMKTS:TIIAY

$4.58 +0.04 (+0.88%)
As of 02:29 PM Eastern

Telecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom Italia

Market Capitalization
$9.78 billion
Consensus Rating
Buy
Volume
6,770 shares
Average Volume
11,249 shares
Today's Range
$4.58
$4.61
50-Day Range
$4.21
$4.90
zSpace stock logo

12. zSpace NASDAQ:ZSPC

$2.74 -0.09 (-3.18%)
As of 03:09 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$63.83 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+447.4% Upside)
Volume
86,038 shares
Average Volume
67,819 shares
Today's Range
$2.40
$2.88
Beyond Air stock logo

13. Beyond Air NASDAQ:XAIR

$2.82 -0.16 (-5.20%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond Air

Market Capitalization
$13.11 million
P/E Ratio
-0.18
Consensus Rating
Buy
Consensus Price Target
$23.67 (+737.8% Upside)
Volume
99,333 shares
Average Volume
152,704 shares
TuHURA Biosciences stock logo

14. TuHURA Biosciences NASDAQ:HURA

$2.41 -0.07 (-2.82%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$105.27 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+425.6% Upside)
Volume
67,690 shares
Average Volume
237,009 shares
Today's Range
$2.37
$2.53
atai Life Sciences stock logo

15. atai Life Sciences NASDAQ:ATAI

$4.20 +0.10 (+2.51%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$840.43 million
P/E Ratio
-4.61
Consensus Rating
Buy
Consensus Price Target
$11.25 (+167.7% Upside)
Volume
6.68 million shares
Average Volume
3.54 million shares
Serve Robotics stock logo

16. Serve Robotics NASDAQ:SERV

$9.94 -0.25 (-2.40%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve Robotics

Market Capitalization
$566.96 million
P/E Ratio
-9.38
Consensus Rating
Buy
Consensus Price Target
$18.67 (+87.7% Upside)
Volume
3.13 million shares
Average Volume
7.32 million shares
VNET Group stock logo

17. VNET Group NASDAQ:VNET

$7.48 -0.83 (-9.93%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET Group

Market Capitalization
$2.02 billion
P/E Ratio
-750.20
Consensus Rating
Buy
Consensus Price Target
$9.30 (+24.2% Upside)
Volume
7.03 million shares
Average Volume
8.18 million shares
OnKure Therapeutics stock logo

18. OnKure Therapeutics NASDAQ:OKUR

$2.18 -0.03 (-1.36%)
As of 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$29.45 million
P/E Ratio
-0.41
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,383.2% Upside)
Volume
16,399 shares
Average Volume
108,078 shares
Sky Harbour Group stock logo

19. Sky Harbour Group NYSEAMERICAN:SKYH

$9.47 -0.30 (-3.07%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sky Harbour Group Corporation operates as an aviation infrastructure development company in the United States. It develops, leases, and manages general aviation hangars for business aircraft. More about Sky Harbour Group

Market Capitalization
$716.03 million
P/E Ratio
-4.57
Consensus Rating
Buy
Consensus Price Target
$17.38 (+83.5% Upside)
Volume
98,860 shares
Average Volume
137,306 shares
Franklin BSP Realty Trust stock logo

20. Franklin BSP Realty Trust NYSE:FBRT

$10.42 +0.33 (+3.22%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). More about Franklin BSP Realty Trust

Market Capitalization
$858.24 million
P/E Ratio
10.65
Consensus Rating
Buy
Consensus Price Target
$15.13 (+45.1% Upside)
Volume
762,669 shares
Average Volume
517,293 shares
Coeur Mining stock logo

21. Coeur Mining NYSE:CDE

$8.65 -0.04 (-0.40%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Coeur Mining, Inc explores for precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. More about Coeur Mining

Market Capitalization
$5.54 billion
P/E Ratio
33.29
Consensus Rating
Buy
Consensus Price Target
$9.21 (+6.5% Upside)
Volume
8.64 million shares
Average Volume
16.65 million shares
NexGen Energy stock logo

22. NexGen Energy NYSE:NXE

$6.46 -0.25 (-3.65%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$3.69 billion
P/E Ratio
-40.40
Consensus Rating
Buy
Volume
5.40 million shares
Average Volume
9.51 million shares
Today's Range
$6.30
$6.53
Western Copper & Gold stock logo

23. Western Copper & Gold NYSE:WRN

$1.19 -0.04 (-3.25%)
As of 03:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$238.90 million
P/E Ratio
-59.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+236.1% Upside)
Volume
99,025 shares
Average Volume
368,987 shares
Trevi Therapeutics stock logo

24. Trevi Therapeutics NASDAQ:TRVI

$7.46 +0.06 (+0.74%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Trevi Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. More about Trevi Therapeutics

Market Capitalization
$876.77 million
P/E Ratio
-16.61
Consensus Rating
Buy
Consensus Price Target
$20.88 (+179.6% Upside)
Volume
940,549 shares
Average Volume
1.86 million shares
Astria Therapeutics stock logo

25. Astria Therapeutics NASDAQ:ATXS

$6.70 -0.22 (-3.16%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria Therapeutics

Market Capitalization
$377.24 million
P/E Ratio
-3.57
Consensus Rating
Buy
Consensus Price Target
$29.00 (+332.8% Upside)
Volume
126,302 shares
Average Volume
365,313 shares